Orthogen AG and its Members
The biotech research company was founded in 1993 and employs around 20 people with various scientific qualifications and experiences. Orthogen AG is a privately held Holdings Company located in Dusseldorf, Germany where its founder and CEO,
Prof. (USA) Dr. Peter Wehling and his management team reside.
Part of our core competency is creating molecular/biological insights, patenting those discoveries and technologies and bringing these to patients in need.
Management Team
Peter Wehling, MD, PhD
CEO and Founder of Orthogen AG
-
Pioneer in the field of Regenerative Medicine and Molecular Orthopedics
-
Specialist in orthopedics and sports medicine with focus on the treatment of chronic pain and care of top athletes
-
Member of the medical faculty at Heinrich-Heine-University Düsseldorf, Germany, and Professor adj. at Duke University, NC, USA
Julio Reinecke, PhD
CSO and Co-Founder of Orthogen AG
-
established laboratory and production infrastructure as well as biotechnology methods
-
Research focus on autologous biologic treatments and local inflammatory conditions such as Osteoarthritis
Supervisory Board
Strategic Advisors

Michael Hamilton
Consultant Strategy Projects for Orthogen AG
-
Managing Director of Triangle BioVentures
-
Former VP, global commercial strategy (infectious diseases) and former VP, global product strategy (neuroscience) at GlaxoSmithKline
-
Former CEO of ALG Therapeutics

Klaus Wehling
Legal Consultant for Orthogen AG
-
Co-Founder of Orthogen AG
-
CFO of Orthogen AG for 20 years (until the end of 2020)
-
Consultant for legal and commercial matters
In Honor
William Maixner, DDS, PhD
Former Member of the Supervisory Board
deceased on Nov 2nd, 2020
-
Former President of the American Pain Society
-
Director Innovative Pain Therapies at Duke University
-
Co-Director of the Center for Translational Pain Medicine (CTPM) at Duke University
Get an insight into our office spaces and laboratories in the heart of Düsseldorf, Germany.